To determine whether WFA-mediated disruption of vimentin IF impairs LUAD progression, KPV+/+ mice were administered WFA (4 mg/kg, QOD, p.o.)2 weeks after Ad-Cre treatment to initiate tumor development (Fig. 4A). Here, VIM is linked to neoplasm.